SLXP

SALIX PHARMACEUTICALS LTD DEL
SLXP

Delisted

SLXP was delisted on the 31st of March, 2015.

304 hedge funds and large institutions have $6.82B invested in SALIX PHARMACEUTICALS LTD DEL in 2014 Q1 according to their latest regulatory filings, with 78 funds opening new positions, 110 increasing their positions, 98 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

more funds holding

Funds holding:

12% more repeat investments, than reductions

Existing positions increased: 110 | Existing positions reduced: 98

8% more capital invested

Capital invested by funds: $6.3B → $6.82B (+$520M)

Holders
304
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$81.1M
Puts
$29.7M
Net Calls
Net Calls Change

Top Buyers

1 +$161M
2 +$75.1M
3 +$59.9M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$55.9M
5
JP Morgan Chase
JP Morgan Chase
New York
+$36.4M
Name Holding Trade Value Shares
Change
Change in
Stake
251
$375K
252
$373K
253
$348K
254
$342K
255
$339K
256
$300K
257
$280K
258
$266K
259
$266K
260
$249K
261
$238K
262
$238K
263
$228K
264
$225K
265
$220K
266
$218K
267
$209K
268
$206K
269
$202K
270
$201K
271
$187K
272
$167K
273
$139K
274
$132K
275
$124K